ACTINIUM PHARMACEUTICALS INC (ATNM) Stock Analyst Earnings Estimates
NYSEARCA:ATNM - NYSE Arca - US00507W2061 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.144M | 1.03M -9.97% | 81K -92.14% | 193.117K 138.42% | 32.94M 16,957.05% | 47.94K -99.85% | 17.986M 37,417.73% | 47.252M 162.72% | 145.03M 206.93% | 182.29M 25.69% | 253.97M 39.32% | 419.45M 65.16% | |
| EBITDA YoY % growth | -24.44M -11.36% | -33.405M -36.68% | -51.13M -53.06% | -49.572M 3.05% | -50.592M -2.06% | -53.142M -5.04% | -60.486M -13.82% | -68.952M -14.00% | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -24.964M -11.48% | -34.104M -36.61% | -51.92M -52.24% | -47.784M 7.97% | -43.81M 8.32% | -58.649M -33.87% | -48.82M 16.76% | -32.917M 32.58% | 45.146M 237.15% | 61.734M 36.74% | 109.77M 77.81% | 208.32M 89.78% | |
| Operating Margin | -2,182.17% | -3,311.07% | -64,098.77% | -24,743.57% | -133.00% | -122,338.30% | -271.43% | -69.66% | 31.13% | 33.87% | 43.22% | 49.67% | |
| EPS YoY % growth | -1.20 41.18% | -1.37 -14.17% | -1.84 -34.31% | -1.43 22.42% | -0.95 33.63% | -1.14 -20.31% | -1.07 6.34% | -0.93 12.74% | -0.12 87.41% | 0.55 569.57% | 1.32 139.81% | 1.97 49.03% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.38 -12.20% | -0.39 -25.03% | 0.07 118.79% | -0.42 -14.41% | -0.34 10.43% | -0.58 -50.00% | -0.54 -857.14% | -0.49 -15.66% |
| Revenue Q2Q % growth | -100.00% | 18.164M | 628.83K | 1.886M | 8.429M | 10.145M -44.15% | 11.861M 1,786.20% | |
| EBITDA Q2Q % growth | -14.28M -49.48% | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -12.542M -21.26% | -12.685M -32.17% | 3.568M 128.73% | -14.276M -13.29% | -15.307M -22.05% | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.37 24.49% | -0.34 | -0.03 | -7.96% |
| Q2 2024 Q2Q % growth | -0.38 34.48% | -0.41 | 0.03 | 8.01% |
| Q1 2024 Q2Q % growth | -0.31 27.91% | -0.53 | 0.22 | 41.55% |
| Q4 2023 Q2Q % growth | -0.34 20.93% | -0.55 | 0.21 | 38.27% |
| Q3 2023 Q2Q % growth | -0.49 -28.95% | -0.54 | 0.05 | 9.64% |
| Q2 2023 Q2Q % growth | -0.58 -75.76% | -0.49 | -0.09 | -18.46% |
| Q1 2023 Q2Q % growth | -0.43 -86.96% | -0.43 | 0.00 | 0.42% |
| Q4 2022 Q2Q % growth | -0.43 -19.44% | -0.36 | -0.07 | -18.75% |
| Q3 2022 Q2Q % growth | -0.38 -26.67% | -0.31 | -0.07 | -22.15% |
| Q2 2022 Q2Q % growth | -0.33 -32.00% | 0.52 | -0.85 | -164.07% |
| Q1 2022 Q2Q % growth | -0.23 20.69% | -0.32 | 0.09 | 28.42% |
| Q4 2021 Q2Q % growth | -0.36 2.70% | -0.31 | -0.05 | -15.72% |
| Q3 2021 Q2Q % growth | -0.30 16.67% | -0.28 | -0.02 | -5.80% |
| Q2 2021 Q2Q % growth | -0.25 39.02% | -0.30 | 0.05 | 17.61% |
| Q1 2021 Q2Q % growth | -0.29 67.78% | -0.30 | 0.01 | 3.07% |
| Q4 2020 Q2Q % growth | -0.37 58.89% | -0.38 | 0.01 | 1.96% |
| Q3 2020 Q2Q % growth | -0.36 70.00% | -0.45 | 0.09 | 20.24% |
| Q2 2020 Q2Q % growth | -0.41 54.44% | -0.41 | 0.00 | -0.52% |
| Q1 2020 Q2Q % growth | -0.90 40.00% | -0.71 | -0.19 | -26.07% |
| Q4 2019 Q2Q % growth | -0.90 | -1.22 | 0.32 | 26.47% |
| Q3 2019 Q2Q % growth | -1.20 | -1.12 | -0.08 | -6.94% |
| Q2 2019 Q2Q % growth | -0.90 | -1.22 | 0.32 | 26.47% |
| Q1 2019 Q2Q % growth | -1.50 | -1.73 | 0.23 | 13.50% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2023 Q2Q % growth | -100.00% | 586.5K | -586.5K | -100.00% |
| Q2 2023 Q2Q % growth | -100.00% | % | ||
| Q1 2023 Q2Q % growth | -100.00% | % | ||
| Q4 2022 Q2Q % growth | -100.00% | 1.055M | -1.055M | -100.00% |
| Q3 2022 Q2Q % growth | 45K -80.69% | 500.647K | -455.647K | -91.01% |
| Q2 2022 Q2Q % growth | 45K -83.08% | 17.85M | -17.805M | -99.75% |
| Q1 2022 Q2Q % growth | 940K 51.13% | 940K | % | |
| Q4 2021 Q2Q % growth | 23K | 81.6K | -58.6K | -71.81% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 2.22% | 23.67% | -5.07% | -5.07% |
| Revenue | N/A | N/A | 0% | -16.67% |